Skip to main content

Advertisement

SpringerLink
Log in

An evaluation of health-related quality of life in patients with systemic lupus erythematosus using PROMIS and Neuro-QoL

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Systemic lupus erythematosus (SLE) is a multi-organ chronic autoimmune disease that can negatively affect patients’ health-related quality of life (HRQOL). This study evaluated HRQOL of SLE patients using questionnaires from the Patient-Reported Outcomes Measurement Information System (PROMIS) and Quality of Life in Neurological Disorders (Neuro-QoL). Individuals with SLE completed an online survey consisting of the PROMIS-29 health profile, PROMIS Psychosocial Illness Impact-Negative, and Neuro-QoL Applied Cognition. PROMIS and Neuro-QoL scores have a mean of 50 in the US general population. Patients self-rated SLE disease severity as negligible, mild, moderate, or severe. Of the 333 participants (mean age 45 years; 92% female; 26% Black; mean SLE disease duration 12 years, 56% with SLE disease severity as moderate or severe), mean HRQOL scores were worse than those of the general population by ≥0.5 SD with the greatest deficits observed in the domains of fatigue, applied cognition, psychosocial illness impact-negative, pain interference, and physical function. Greater SLE disease severity was associated with worse mean HRQOL scores (all p < 0.05). Pain severity was also associated with worse HRQOL scores on all domains (p < 0.05) except for satisfaction with social role. Test-retest reliability exceeded 0.70 for all PROMIS and Neuro-QoL scores. PROMIS-29 and Neuro-QoL are valid tools to assess HRQOL in patients with SLE. These patients reported substantial deficits that correlated with their SLE disease severity, with pain being an important independent contributor. These deficits should be monitored in SLE patients during their routine clinical care and evaluated when investigating new therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Gill JM, Quisel AM, Rocca PV, Walters DT (2003) Diagnosis of systemic lupus erythematosus. Am Fam Physician 68(11):2179–2186

    PubMed  Google Scholar 

  2. Pons-Estel GJ, Alarcón GS, Scofield L, Reinlib L, Cooper GS (2010) Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum 39(4):257–268

    Article  PubMed  Google Scholar 

  3. Wang C, Mayo NE, Fortin PR (2001) The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus. J Rheumatol 28(3):525–532

    CAS  PubMed  Google Scholar 

  4. Drenkard C, Alarcon-Segovia D (2000) The new prognosis of systemic lupus erythematosus: treatment-free remission and decreased mortality and morbidity. IsrMedAssocJ 2(5):382–387

    CAS  Google Scholar 

  5. Lau CS, Mak A (2009) The socioeconomic burden of SLE. Nat Rev Rheumatol 5(7):400–404

    Article  PubMed  Google Scholar 

  6. Garris C, Oglesby A, Sulcs E, Lee M (2013) Impact of systemic lupus erythematosus on burden of illness and work productivity in the United States. Lupus 22(10):1077–1086

    Article  CAS  PubMed  Google Scholar 

  7. Leong KP, Kong KO, Thong BYH, Koh ET, Lian TY, Teh CL, Cheng YK, Chng HH, Badsha H, Law WG, Lau TC, Chew LC, Ho HJ, Pong LY, Hoi LS, Sangeetha N, Chan SP, Howe HS (2005) Development and preliminary validation of a systemic lupus erythematosus-specific quality-of-life instrument (SLEQOL). Rheumatology 44(10):1267–1276

    Article  CAS  PubMed  Google Scholar 

  8. McElhone K, Abbott J, Shelmerdine J, Bruce IN, Ahmad Y, Gordon C, Peers K, Isenberg D, Ferenkeh-Koroma A, Griffiths B (2007) Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus. Arthritis Care & Research 57(6):972–979

    Article  Google Scholar 

  9. Petri M, Kawata AK, Fernandes AW, Gajria K, Greth W, Hareendran A, Ethgen D (2013) Impaired health status and the effect of pain and fatigue on functioning in clinical trial patients with systemic lupus erythematosus. J Rheumatol 40(11):1865–1874

    Article  PubMed  Google Scholar 

  10. Al Dhanhani AM, Gignac MA, Su J, Fortin PR (2009) Work disability in systemic lupus erythematosus. Arthritis Rheum 61(3):378–385

    Article  PubMed  Google Scholar 

  11. Rood MJ, Borggreve SE, Huizinga TW (2000) Sensitivity to change of the MOS SF-36 quality of life assessment questionnaire in patients with systemic lupus erythematosus taking immunosuppressive therapy. J Rheumatol 27(8):2057–2059

    CAS  PubMed  Google Scholar 

  12. Cella D, Gershon R, Lai J-S, Choi S (2007) The future of outcomes measurement: item banking, tailored short-forms, and computerized adaptive assessment. Qual Life Res 16(Suppl 1):133–141

    Article  PubMed  Google Scholar 

  13. Rothrock N, Hays R, Spritzer K, Yount SE, Riley W, Cella D (2010) Relative to the general US population, chronic diseases are associated with poorer health-related quality of life as measured by the patient-reported outcomes measurement information system (PROMIS). J Clin Epidemiol 63(11):1195–1204

    Article  PubMed  PubMed Central  Google Scholar 

  14. Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S, Amtmann D, Bode R, Buysse D, Choi S, Cook K, Devellis R, Dewalt D, Fries JF, Gershon R, Hahn EA, Pilkonis P, Revicki D, Rose M, Weinfurt K, Hays R, Lai JS, PROMIS Cooperative Group (2010) The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. J Clin Epidemiol 63(11):1179–1194

    Article  PubMed  PubMed Central  Google Scholar 

  15. Beaumont JL, Cella D, Phan AT, Choi S, Liu Z, Yao JC (2012) Comparison of health-related quality of life in patients with neuroendocrine tumors with quality of life in the general US population. Pancreas 41(3):461–466

    Article  CAS  PubMed  Google Scholar 

  16. Lai JS, Garcia SF, Salsman JM, Rosenbloom S, Cella D (2012) The psychosocial impact of cancer: evidence in support of independent general positive and negative components. Qual Life Res 21(2):195–207

    Article  PubMed  Google Scholar 

  17. Garcia SF, Lai JS, Salsman JM, Cella D (2010) Development of the patient-reported outcomes measurement information system (PROMIS) psychosocial illness impact item banks [abstract]. Psycho-Oncology 19(1, Suppl):S2

    Google Scholar 

  18. Maneeton B, Maneeton N, Louthrenoo W (2010) Cognitive deficit in patients with systemic lupus erythematosus. Asian Pac J Allergy Immunol 28(1):77–83

    PubMed  Google Scholar 

  19. Cella D, Lai JS, Nowinski C, Victorson D, Peterman A, Miller D, Bethoux F, Heinemann A, Rubin S, Cavasos J, Reder A, Sufit R, Simuni T, Holmes G, Siderowf A, Wojna V, Bode R, McKinney N, Podrabsky T, Wortman K, Choi S, Gershon R, Rothrock N, Moy C (2012) Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology. Neurology 78:1860–1867

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Liu H, Cella D, Gershon R, Shen J, Morales LS, Riley W, Hays RD (2010) Representativeness of the PROMIS internet panel. J Clin Epidemiol 63(11):1169–1178

    Article  PubMed  PubMed Central  Google Scholar 

  21. Gershon R, Lai J, Bode R, Choi S, Moy C, Bleck T, Miller D, Peterman A, Cella D (2012) Neuro-QOL: quality of life item banks for adults with neurological disorders: item development and calibrations based upon clinical and general population testing. Qual Life Res 21(3):475–486

    Article  PubMed  Google Scholar 

  22. Waldheim E, Elkan A, Pettersson S, van Vollenhoven R, Bergman S, Frostegård J, Henriksson EW (2013) Health-related quality of life, fatigue and mood in patients with SLE and high levels of pain compared to controls and patients with low levels of pain. Lupus 22(11):1118–1127

    Article  CAS  PubMed  Google Scholar 

  23. Jolly M (2005) How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses? J Rheumatol 32(9):1706–1708

    PubMed  Google Scholar 

  24. Lai J-S, Cella D, Yanez B, Stone A (2014) Linking fatigue measures on a common reporting metric. J Pain Symptom Manag 48(4):639–648

    Article  Google Scholar 

  25. Lai J-S, Beaumont J, Ogale S, Brunetta P, Cella D (2011) Validation of the functional assessment of chronic illness therapy-fatigue (FACIT-fatigue) scale in patients with moderately to severely active SLE, participating in a clinical trial. J Rheumatol 38(4):672–679

    Article  PubMed  Google Scholar 

  26. Schmeding A, Schneider M (2013) Fatigue, health-related quality of life and other patient-reported outcomes in systemic lupus erythematosus. Best practice and research. Clin Rheumatol 27(3):363–375

    CAS  Google Scholar 

  27. Feld J, Isenberg D (2014) Why and how should we measure disease activity and damage in lupus? Presse Med 43(6 Pt 2):e151–e156

    Article  PubMed  Google Scholar 

  28. Archenholtz B, Burckhardt CS, Segesten K (1999) Quality of life of women with systemic lupus erythematosus or rheumatoid arthritis: domains of importance and dissatisfaction. Qual Life Res 8(5):411–416

    Article  CAS  PubMed  Google Scholar 

  29. Thumboo J, Fong KY, Chan SP, Leong KH, Feng PH, Thio ST, Boey ML (2000) A prospective study of factors affecting quality of life in systemic lupus erythematosus. J Rheumatol 27(6):1414–1420

    CAS  PubMed  Google Scholar 

  30. Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, Urowitz M, Fortin PR, Petri M, Barr S, Gordon C, Bae SC, Isenberg D, Zoma A, Aranow C, Dooley MA, Nived O, Sturfelt G, Steinsson K, Alarcon G, Senecal JL, Zummer M, Hanly J, Ensworth S, Pope J, Edworthy S, Rahman A, Sibley J, El-Gabalawy H, McCarthy T, St Pierre Y, Clarke A, Ramsey-Goldman R (2006) Mortality in systemic lupus erythematosus. Arthritis Rheum 54(8):2550–2557

    Article  CAS  PubMed  Google Scholar 

  31. Bichile T, Petri M (2014) Prevention and management of co-morbidities in SLE. Presse Med 43(6 Pt 2):e187–e195

    Article  PubMed  Google Scholar 

  32. Gladman D, Urowitz M, Fortin P, Isenberg D, Goldsmith C, Gordon C, Petri M (1996) Systemic lupus international collaborating clinics conference on assessment of lupus flare and quality of life measures in SLE. Systemic Lupus International Collaborating Clinics Group. J Rheumatol 23(11):1953–1955

    CAS  PubMed  Google Scholar 

  33. Urowitz M, Gladman D, Ibañez D, Sanchez-Guerrero J, Bae S, Gordon C, Fortin P, Clarke A, Bernatsky S, Hanly J (2014) Changes in quality of life in the first 5 years of disease in a multicentre cohort of patients with systemic lupus erythematosus (SLE). Arthritis Care Res 66(9):1374–1379

    Article  CAS  Google Scholar 

  34. Lai JS, Cella D, Choi SW, Junghaenel DU, Christodolou C, Gershon R, Stone A (2011) How item banks and their application can influence measurement practice in rehabilitation medicine: a PROMIS fatigue item bank example. Arch Phys Med Rehabil 92(10 Supplement):S20–S27

    Article  PubMed  PubMed Central  Google Scholar 

  35. Uribe AG, McGwin G, Reveille JD, Alarcón GS (2004) What have we learned from a 10-year experience with the LUMINA (lupus in minorities; nature vs. nurture) cohort? Where are we heading? Autoimmun Rev 3(4):321–329

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This project was funded by Biogen.

Author information

Authors and Affiliations

  1. Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, 633 N St Clair, 19th Floor, Chicago, IL, 60611, USA

    Jin-Shei Lai, Jennifer L. Beaumont, Sally E. Jensen & Karen Kaiser

  2. Biogen Idec Inc, Cambridge, MA, USA

    David L. Van Brunt, Amy H. Kao & Shih-Yin Chen

Authors
  1. Jin-Shei Lai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jennifer L. Beaumont
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sally E. Jensen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Karen Kaiser
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. David L. Van Brunt
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Amy H. Kao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shih-Yin Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jin-Shei Lai.

Ethics declarations

Disclosure

Shih-Yin Chen is an employee and shareholder of Biogen. David Van Brunt and Amy Kao were employees of Biogen when the study was conducted, and are shareholders. The Northwestern investigators have no conflicts of interest to declare. Biogen reviewed and provided feedback on the manuscript to the authors. The authors had full editorial control of the manuscript, and provided their final approval of the content.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lai, JS., Beaumont, J.L., Jensen, S.E. et al. An evaluation of health-related quality of life in patients with systemic lupus erythematosus using PROMIS and Neuro-QoL. Clin Rheumatol 36, 555–562 (2017). https://doi.org/10.1007/s10067-016-3476-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-016-3476-6

Keywords

Search

Navigation